Null genetic risk of ACE gene polymorphisms with nephropathy in type 1 diabetes among Egyptian population

Reported to date, strong evidence exists in multiple studies for genetic predisposing in the development of diabetic nephropathy, and no studies addressed this issue among Egyptian pop- ulation. The results of angiotensin converting enzyme gene (ACE) in the susceptibility to nephrop- athy in type 1 diabetes with nephropathy are conflicting. We aim to identify the associations of two ACE gene polymorphisms (PstI, A > G substitution and a 287-bp insertion/deletion) with nephropathy in type 1 diabetes in Egyptian children/adolescents. Our case-control study contained 140 diabetic individuals; 80 diabetic with nephropathy as cases, and 60 diabetic subjects without nephropathy as control group. Amplified DNA from peripheral leucocytes/buccal mucosa was gen- otyped for using polymerase chain reaction and enzymatic assay. We found no significant differ- ences in the distribution of ACE insertion/deletion and PstI genotypes or allele frequencies were observed between the examined groups. Frequencies of PstI-indel haplotypes were similar in all of our study groups. In both cases and control subjects, ACE activity and microalbuminuria were highest among D/D homozygotes and lowest in I/I homozygotes, while a dissimilar result was seen

[1]  F. Soubrier,et al.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). , 1992, Nucleic acids research.

[2]  M. F. Saad,et al.  Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus , 1990, Diabetologia.

[3]  O. Dekkers,et al.  Genetic associations in diabetic nephropathy: a meta-analysis , 2010, Diabetologia.

[4]  F. Ziyadeh.  Renal tubular basement membrane and collagen type IV in diabetes mellitus. , 1993, Kidney international.

[5]  J. Connell,et al.  Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. , 1995, Hypertension.

[6]  A. Krolewski,et al.  Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of the Angiotensin I–Converting Enzyme Gene , 1994, Diabetes.

[7]  E. Ritz,et al.  Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[9]  W. Grzeszczak,et al.  Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus. , 1998, Journal of the American Society of Nephrology : JASN.

[10]  H. Parving,et al.  Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  I. Ichikawa,et al.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. , 1995, The Journal of clinical investigation.

[12]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[13]  S. Rich,et al.  Angiotensin I-converting enzyme (ACE): estimation of DNA haplotypes in unrelated individuals using denaturing gradient gel blots , 1994, Human Genetics.

[14]  J. Flier,et al.  Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. , 1987, The New England journal of medicine.

[15]  W. Herman,et al.  Does microalbuminuria predict diabetic nephropathy? , 2001, Diabetes care.

[16]  R. Osterby,et al.  Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria. , 2000, Diabetes care.

[17]  N. Brown,et al.  ACE insertion/deletion genotype affects bradykinin metabolism. , 1998, Journal of cardiovascular pharmacology.

[18]  J. J. Jayapalan,et al.  Angiotensin-1 converting enzyme I/D gene polymorphism: scenario in Malaysia. , 2008, The Southeast Asian journal of tropical medicine and public health.

[19]  N. Perico,et al.  Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. , 1993, Journal of the American Society of Nephrology : JASN.

[20]  A. Krolewski,et al.  Familial factors determine the development of diabetic nephropathy in patients with IDDM , 1996, Diabetologia.

[21]  S. Chan,et al.  Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects , 2010, Indian journal of human genetics.

[22]  A. Krolewski,et al.  DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes mellitus. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[24]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[25]  F. Cambien,et al.  Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications , 1994, Diabetes.